Occuspace raises $3.6M in seed funding
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Update: The Trade Desk co-founder steps down
Dave Pickles, who co-founded Ventura-based The Trade Desk alongside CEO Jeff Green, announced he will be stepping down as Chief Technology Officer on Sept. 29. Pickles will also step down from his role on the company’s board of directors, The Trade Desk announced in an Aug. 30 press release. Although he is retiring from these Read More →
Sonos drops out of top three in patent sweepstakes
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Mercado: Three tech trends to keep an eye on across the Central Coast as summer ends
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Looking the part: Launchpoint finds new home to showcase growing business
It has been a few years since Launchpoint Electric Propulsion Solutions struck out on its own, being spun out of the now-defunct Launchpoint Technologies, but now, the company is ready for takeoff. Launchpoint EPS moved into its new facility at 320 Storke Rd. in early August, upping its presence in the region for the new Read More →
FTC settles lawsuit, paves way for Amgen’s $28B purchase of Horizon Therapeutics
The Federal Trade Commission entered into a consent agreement with Amgen and Horizon Therapeutics, clearing the way for Amgen’s $28 billion acquisition of Horizon to go through. Announced on Sept. 1, Amgen agreed to not use its drug list to inhibit competition for Tepezza and Krystezza, which are Horizon’s biggest two drugs and the only Read More →
Umbra captures revenue with satellite snapshots
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
